UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z
Number of items: 340.

A

Ahmed, F; Ings, SJ; Pizzey, AR; Blundell, MP; Thrasher, AJ; T Ye, H; ... Yong, KL; + view all (2004) Impaired bone marrow homing of cytokine-activated CD34(+) cells in the NOD/SCID model. BLOOD , 103 (6) 2079 - 2087. 10.1182/blood-2003-06-1770.

Ali, K; Bilancio, A; Pearce, W; Peskett, E; Sawyer, C; Okkenhaug, K; ... Gray, A; + view all (2004) Essential role for the p110δ phosphoinositide 3-kinase in the allergic response. Nature , 431 (7011) 1007 - 1011. 10.1038/nature02991.

Ali, K; Bilancio, A; Thomas, M; Pearce, W; Gilfillan, AM; Tkaczyk, C; ... Vanhaesebroeck, B; + view all (2004) Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature , 431 (7011) 1007 - 1011. 10.1038/nature02991.

Allen, AJR; Nash, MJ; Linch, DC; Gale, RE; (2004) Increased expression of the low affinity IgG receptor FcR gamma IIA (CD32) in platelet RNA from patients with chronic myeloproliferative disorders demonstrated by representational difference analysis. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 39 - 39). BLACKWELL PUBLISHING LTD

Alley, MC; Hollingshead, MG; Pacula-Cox, CM; Wand, WR; Hartley, JA; Howard, PW; ... Sausville, EA; + view all (2004) SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 2: Efficacy evaluations. CANCER RES , 64 (18) 6700 - 6706.

Anderson, LJ; Westwood, MA; Holden, S; Davis, B; Prescott, E; Wonke, B; ... Pennell, DJ; + view all (2004) Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2*cardiovascular magnetic resonance. BRIT J HAEMATOL , 127 (3) 348 - 355. 10.1111/j.1365-2141.2004.05202.x.

André, T; Boni, C; Mounedji-Boudiaf, L; Navarro, M; Tabernero, J; Hickish, T; ... Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators,; + view all (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med , 350 (23) 2343 - 2351. 10.1056/NEJMoa032709. Green open access
file

Ansell, SM; Arendt, BK; Grote, DM; Jelinek, DF; Novak, AJ; Wellik, LE; ... Fielding, A; + view all (2004) Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. Leukemia , 18 (3) 616 - 623. 10.1038/sj.leu.2403281.

Ansell, SM; Wellik, LE; Fielding, A; Arendt, BK; Jelinek, DF; Novak, AJ; ... Bennett, CF; + view all (2004) Inihibitor of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. Leukemia , 18 (3) 616 - 623. 10.1038/sj.leu.2403281.

Antoniou, AN; Ford, S; Taurog, JD; Butcher, GW; Powis, SJ; (2004) Formation of HLA-B27 homodimers and their relationship to assembly kinetics. J BIOL CHEM , 279 (10) 8895 - 8902. 10.1074/jbc.M311757200. Gold open access

Attygalle, AD; Diss, TC; Munson, P; Isaacson, PG; Du, MQ; Dogan, A; (2004) CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma. Am J Surg Pathol , 28 (1) 54 - 61.

Attygalle, AD; Liu, H; Shirali, S; Diss, TC; Loddenkemper, C; Stein, H; ... Isaacson, PG; + view all (2004) Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood , 104 (10) 3343 - 3348. 10.1182/blood-2004-01-0385. Green open access
file

Avivi, I; Chakrabarti, S; Kottaridis, P; Kyriaku, C; Dogan, A; Milligan, D; ... Mackinnon, S; + view all (2004) Neurological complications following alemtuzumab-based reduced- intensity allogeneic transplantation. BONE MARROW TRANSPLANTATION , 34 (2) 137 - 142.

Avivi, I; Chakrabarti, S; Kottaridis, P; Kyriaku, C; Dogan, A; Milligan, DW; ... Mackinnon, S; + view all (2004) Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation. Bone Marrow Transplant , 34 (2) 137 - 142. 10.1038/sj.bmt.1704538.

Avivi, I; Chakrabarti, S; Milligan, DW; Waldmann, H; Hale, G; Osman, H; ... MacKinnon, S; + view all (2004) Incidence and outcome of Adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. BIOL BLOOD MARROW TR , 10 (3) 186 - 194. 10.1016/j.bbmt.2003.11.001.

Avivi, I; Chakrabarti, S; Milligan, DW; Waldmann, H; Hale, G; Osman, H; ... Mackinnon, S; + view all (2004) Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. Biol Blood Marrow Transplant , 10 (3) 186 - 194. 10.1016/j.bbmt.2003.11.001.

B

Bagshawe, KD; Sharma, SK; Begent, RHJ; (2004) Antibody-directed enzyme prodrug therapy (ADEPT) for cancer. EXPERT OPIN BIOL TH , 4 (11) 1777 - 1789. 10.1517/14712598.4.11.1777.

Balsa, C; Watts, MJ; Ings, SJ; Linch, DC; (2004) Unexpected differences in the thaw clonogenic recovery of pre-stressed peripheral blood stem cells according to the cryoprotectant used. In: BONE MARROW TRANSPLANTATION. (pp. S93 - S93). NATURE PUBLISHING GROUP

Baraldi, PG; Beria, I; Cozzi, P; Geroni, C; Espinosa, A; Gallo, MA; ... Romagnoli, R; + view all (2004) Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies. BIOORGAN MED CHEM , 12 (14) 3911 - 3921. 10.1016/j.bmc.2004.04.045.

Barber, L; Whitelegg, A; Madrigal, J; Banner, N; Rose, M; (2004) Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. TRANSPLANTATION , 77 (10) 1604 - 1609.

Bates, AW; (2004) The sooterkin doctor: the London career of John Maubray, MD (1700-1732), "andro-boethogynist". J Med Biogr , 12 (3) 147 - 153.

Beck, S; (2004) Dr Nat Bumstead: Pioneer researcher in mapping the chicken genome. DNA SEQUENCE , 15 (3) 165 - 166. 10.1080/10425170410001716073.

Beck, S; (2004) Haplotypes revisited: Genetic and epigenetic variation of the MHC. In: TISSUE ANTIGENS. (pp. 327 - 328). BLACKWELL MUNKSGAARD

Bell, CG; Benzinou, M; Siddiq, A; Lecoeur, C; Dina, C; Lemainque, A; ... Froguel, P; + view all (2004) Genome-wide linkage analysis for severe obesity in french caucasians finds significant susceptibility locus on chromosome 19q. Diabetes , 53 (7) 1857 - 1865.

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Melino, G; Cossarizza, A; ... Salomoni, P; + view all (2004) Mutant PML proteins form novel cytoplasmic bodies. In: BLOOD. (pp. 952A - 952A). AMER SOC HEMATOLOGY

Belorgey, D; Sharp, LK; Crowther, DC; Onda, M; Johansson, J; Lomas, DA; (2004) Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB. Eur J Biochem , 271 (16) 3360 - 3367. 10.1111/j.1432-1033.2004.04270.x.

Benchaouir, R; Rameau, P; Decraene, C; Dreyfus, P; Israeli, D; Piétu, G; ... Garcia, L; + view all (2004) Evidence for a resident subset of cells with SP phenotype in the C2C12 myogenic line: a tool to explore muscle stem cell biology. Exp Cell Res , 294 (1) 254 - 268. 10.1016/j.yexcr.2003.11.005.

Bernassola, F; Salomoni, P; Oberst, A; Di Como, CJ; Pagano, M; Melino, G; Pandolfi, PP; (2004) Ubiquitin-dependent degradation of p73 is inhibited by PML. J EXP MED , 199 (11) 1545 - 1557. 10.1084/jem.20031943.

Bouscary, D; Bardet, V; Sujobert, P; Cornillet-Lefebvre, P; Hayflick, JS; Prie, N; ... Lacombe, C; + view all (2004) Blockade of p110delta isoform activity of phosphoinositide 3-kinase inhibits blast cell proliferation in acute myeloblastic leukemia. In: BLOOD. (pp. 691A - 691A).

Bowen, D; Hyslop, A; Keenan, N; Groves, M; Culligan, D; Johnson, P; ... Cavill, I; + view all (2004) Prediction of response to recombinant erythropoietin plus granulocyte-colony stimulating factor following a single subcutaneous bolus in patients with myelodysplastic syndromes; a randomised placebo controlled study. In: BLOOD. (pp. 402A - 402A). AMER SOC HEMATOLOGY

Bower, M; Powles, T; Newsom-Davis, T; Thirlwell, C; Stebbing, J; Mandalia, S; ... Gazzard, B; + view all (2004) HIV-associated anal cancer - Has highly active antiretroviral therapy reduced the incidence or improved the outcome? JAIDS-J ACQ IMM DEF , 37 (5) 1563 - 1565.

Bower, M; Stebbing, J; Thirlwell, C; Newsom-Davis, T; Waterston, A; Mandalia, S; Gazzard, B; (2004) Anti-retroviral treatment regimens and immune parameters in the prevention of systemic HIV-related non-Hodgkin's lymphoma. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 105S - 105S). AMER SOC CLINICAL ONCOLOGY

Boxall, EH; Sira, J; Standish, RA; Davies, P; Sleight, E; Dhillon, AP; ... Kelly, DA; + view all (2004) Natural history of hepatitis B in perinatally infected carriers. ARCH DIS CHILD , 89 (5) F456 - F460. 10.1136/adc.2002.009837.

Bruno, L; Hoffmann, R; McBlane, F; Brown, J; Gupta, R; Joshi, C; ... Enver, T; + view all (2004) Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. MOL CELL BIOL , 24 (2) 741 - 756. 10.1128/MCB.24.2.741-756.2004.

Burroughs, A; Hochhauser, D; Meyer, T; (2004) Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. Lancet Oncol , 5 (7) 409 - 418. 10.1016/S1470-2045(04)01508-6.

Butcher, LM; Meaburn, E; Liu, L; Fernandes, C; Hill, L; Al-Chalabi, A; ... Craig, IW; + view all (2004) Genotyping pooled DNA on microarrays: a systematic genome screen of thousands of SNPs in large samples to detect QTLs for complex traits. Behav.Genet. , 34 (5) 549 - 555. 10.1023/B:BEGE.0000038493.26202.d3.

Byrne, E; (2004) The physician scientist: an endangered breed? Internal Medicine Journal , 34 (3) 75 - 75.

C

Calabrese, CR; Almassy, R; Barton, S; Batey, MA; Calvert, AH; Canan-Koch, S; ... Curtin, NJ; + view all (2004) Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361. J NATL CANCER I , 96 (1) 56 - 67. 10.1093/jnci/djh005.

Callies, S; de Alwis, DP; Mehta, A; Burgess, M; Aarons, L; (2004) Population pharmacokinetic model for daunorubicin and daunorubicinol coadministered with zosuquidar.3HCl (LY335979). Cancer Chemotherapy and Pharmacology , 54 (1) 39 - 48.

Calvert, AH; (2004) Biochemical pharmacology of pemetrexed. Oncology (Williston Park) , 18 (13 Suppl 8) 13 - 17.

Camilleri, RS; Peebles, D; Portmann, C; Everington, T; Cohen, H; (2004) -455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications. BLOOD COAGUL FIBRIN , 15 (2) 139 - 147. 10.1097/01.mbc.0000114378.15192.1a.

Campbell, M; Allen, WE; Sawyer, C; Vanhaesebroeck, B; Trimble, ER; (2004) Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways. Circ Res , 95 (4) 380 - 388. 10.1161/01.RES.0000138019.82184.5d.

Carnell, DM; Smith, RE; Daley, FM; Barber, PR; Hoskin, PJ; Wilson, GD; ... Everett, SA; + view all (2004) Target validation of cytochrome P450CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue. International Journal of Radiation Oncology Biology Physics , 58 (2) 500 - 509.

Carrell, RW; Zhou, AW; Lomas, DA; (2004) Neuroserpin provides a structural model for the causation and rational therapy of dementia. In: NEUROBIOLOGY OF AGING. (pp. S47 - S48).

Castillon, N; Avril-Delplanque, A; Coraux, C; Delenda, C; Péault, B; Danos, O; Puchelle, E; (2004) Regeneration of a well-differentiated human airway surface epithelium by spheroid and lentivirus vector-transduced airway cells. J Gene Med , 6 (8) 846 - 856. 10.1002/jgm.570.

Cavenagh, JD; Popat, R; Curry, N; Stec, J; Morris, TC; Drake, M; ... Oakervee, H; + view all (2004) PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma. In: BLOOD. (pp. 413A - 413A). AMER SOC HEMATOLOGY

Chester, JD; Hall, GD; Forster, M; Protheroe, AS; (2004) Systemic chemotherapy for patients with bladder cancer--current controversies and future directions. Cancer Treat Rev , 30 (4) 343 - 358. 10.1016/j.ctrv.2003.12.005.

Chew, SK; Akdemir, F; Chen, P; Lu, WJ; Mills, K; Daish, T; ... Abrams, JM; + view all (2004) The apical caspase dronc governs programmed and unprogrammed cell death in Drosophila. Dev Cell , 7 (6) 897 - 907. 10.1016/j.devcel.2004.09.016.

Chow, E; Thirlwell, C; Macrae, F; Lipton, L; (2004) Colorectal cancer and inherited mutations in base-excision repair. LANCET ONCOL , 5 (10) 600 - 606.

Chow, MK; Lomas, DA; Bottomley, SP; (2004) Promiscuous beta-strand interactions and the conformational diseases. Curr Med Chem , 11 (4) 491 - 499.

Clamp, A; Adams, M; Atkinson, R; Boven, E; Calvert, AH; Cervantes, A; ... Jayson, GC; + view all (2004) A phase IIA study of the topoisomerase I inhibitor, exatecan mesylate (DX-895 1f), administered at two different dose schedules in patients with platinum- and taxane-resistant/refractory ovarian cancer. GYNECOL ONCOL , 95 (1) 114 - 119. 10.1016/j.ygyno.2004.06.047.

Clark, FJ; Gregg, R; Piper, K; Dunnion, D; Freeman, L; Griffiths, M; ... Chakraverty, R; + view all (2004) Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4(+)CD25(high) regulatory T cells. BLOOD , 103 (6) 2410 - 2416. 10.1182/blood-2003-06-2073.

Clingen, PH; Wu, J; Prise, KM; Hartley, JA; (2004) H2AX nuclear foci are induced in human cells after treatment with DNA interstrand crosslinking chemotherapeutics. BRITISH JOURNAL OF CANCER , 91 S48 - S48.

Coakley, M; Mallet, S; Purdy, G; Self, R; Machin, SJ; Mackie, IJ; (2004) A second cohort of patients with coronary heart disease and reduced VWF cleaving protease activity. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 45 - 45). BLACKWELL PUBLISHING LTD

Cooper, N; Avivi, I; Peggs, K; Hart, D; Thomson, K; Goldstone, A; ... Mackinnon, S; + view all (2004) The role of PET scanning in directing immune manipulations following reduced intensity transplants in adults with lymphoid malignancies. In: BLOOD. (pp. 622A - 623A). AMER SOC HEMATOLOGY

Craig, CEH; Quaglia, A; Dhillon, AP; (2004) Extramedullary haematopoiesis in massive hepatic necrosis. HISTOPATHOLOGY , 45 (5) 518 - 525.

Craig, CEH; Quaglia, A; Dhillon, AP; (2004) Massive hepatic necrosis and extramedullary haemopoiesis. In: JOURNAL OF HEPATOLOGY. (pp. 42 - 42). ELSEVIER SCIENCE BV

Crowther, DC; Belorgey, D; Miranda, E; Kinghorn, KJ; Sharp, LK; Lomas, DA; (2004) Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies. Eur J Hum Genet , 12 (3) 167 - 172. 10.1038/sj.ejhg.5201127.

Crowther, DC; Kinghorn, KJ; Page, R; Lomas, DA; (2004) Therapeutic targets from a Drosophila model of Alzheimer's disease. Curr Opin Pharmacol , 4 (5) 513 - 516. 10.1016/j.coph.2004.07.001.

Curtin, NJ; Barlow, HC; Bowman, KJ; Calvert, AH; Davison, R; Golding, BT; ... Griffin, RJ; + view all (2004) Resistance-modifying agents. 11. Pyrimido[5,4-d]pyrimidine modulators of antitumor drug activity. Synthesis and structure-activity relationships for nucleoside transport inhibition and binding to alpha(1)-acid glycoprotein. J MED CHEM , 47 (20) 4905 - 4922. 10.1021/jm040772w.

D

D'Sa, S; Yong, K; Kyriakou, C; Bhattacharya, S; Peggs, KS; Foulkes, B; ... Williams, CD; + view all (2004) Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects. BRIT J HAEMATOL , 125 (6) 756 - 765. 10.1111/j.1365-2141.2004.04981.x.

Danovi, D; Meulmeester, E; Pasini, D; Migliorini, D; Capra, M; Frenk, R; ... Marine, JC; + view all (2004) Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. MOL CELL BIOL , 24 (13) 5835 - 5843. 10.1128/MCB.24.13.5835-5843.2004.

Davidoff, AM; Nathwani, AC; (2004) Antiangiogenic gene therapy for cancer treatment. Current hematology reports , 3 (4) 267 - 273.

Davidoff, AM; Ng, CYC; Sleep, S; Gray, J; Azam, S; Zhao, Y; ... Nathwani, AC; + view all (2004) Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock. J VIROL METHODS , 121 (2) 209 - 215. 10.1016/j.jviromet.2004.07.001.

Davies, J; Marden, C; Sviland, L; North, J; Lowdell, MW; (2004) Ex-vivo alloreactive T cell depletion with anti-CD69 - Effects on anti-viral immune-reactivity and donor NK cell function. BLOOD CELLS MOLECULES AND DISEASES , 33 (3) 198 - 198.

Davies, JK; Koh, MBC; Lowdell, MW; (2004) Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings. BIOL BLOOD MARROW TR , 10 (4) 259 - 268. 10.1016/j.bbmt.2003.12.001.

Davis, BA; O'Sullivan, C; Jarritt, PH; Porter, JB; (2004) Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. BLOOD , 104 (1) 263 - 269. 10.1182/blood-2003-08-2841.

de Laat, HB; de Groot, PG; Mackie, IJ; Schoormans, S; Adam, M; Purdy, G; ... van Heerde, W; + view all (2004) The role of annexin A5 in the antiphospholipid syndrome. In: THROMBOSIS RESEARCH. (pp. 654 - 654). PERGAMON-ELSEVIER SCIENCE LTD

De Leval, L; Vivario, M; De Prijck, B; Zhou, Y; Boniver, J; Harris, NL; ... Du, MQ; + view all (2004) Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection. The American Journal of Surgical Pathology , 28 679 - 686.

Dearling, JLJ; Flynn, AA; Sutcliffe-Goulden, J; Petrie, IA; Boden, R; Green, AJ; ... Pedley, RB; + view all (2004) Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. J NUCL MED , 45 (1) 101 - 107.

Delaunay, J; Nouyrigat, V; Proust, A; Schischmanoff, PO; Cynober, T; Yvart, J; ... Tchernia, G; + view all (2004) Different impacts of alleles alphaLEPRA and alphaLELY as assessed versus a novel, virtually null allele of the SPTA1 gene in trans. Br J Haematol , 127 (1) 118 - 122. 10.1111/j.1365-2141.2004.05160.x.

Delgado, J; Cooper, N; Thomson, K; Duarte, R; Kottaridis, P; Peggs, K; Mackinnon, S; (2004) The importance of age, fludarabine and total body irradiation in the incidence and severity of chronic renal failure following allogeneic hematopoietic stem cell transplantation. In: BLOOD. (pp. 621A - 621A). AMER SOC HEMATOLOGY

Deloukas, P; Earthrowl, ME; Grafham, DV; Rubenfield, M; French, L; Steward, CA; ... Rogers, J; + view all (2004) The DNA sequence and comparative analysis of human chromosome 10. NATURE , 429 (6990) 375 - 381. 10.1038/nature02462.

Direkze, NC; Hodivala-Dilke, K; Jeffery, R; Hunt, T; Oukrif, D; Preston, SL; ... Wright, NA; + view all (2004) Bone marrow contributes to tumour stroma. In: JOURNAL OF PATHOLOGY. (pp. 10A - 10A). JOHN WILEY & SONS LTD

Direkze, NC; Hodivala-Dilke, K; Jeffery, R; Hunt, T; Poulsom, R; Oukrif, D; ... Wright, NA; + view all (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. CANCER RES , 64 (23) 8492 - 8495.

Duarte, RF; Delgado-Gonzalez, J; Quaglia, AF; Shaw, B; Wrench, D; Ethell, M; ... Potter, MN; + view all (2004) Graft-versus-host disease of the liver: 109 cases from a single-centre. BONE MARROW TRANSPLANTATION , 33 S175 - S175.

Duarte, RF; Delgado-Gonzalez, J; Shaw, BE; Wrench, D; Ethell, M; Patch, D; ... Quaglia, AF; + view all (2004) Pathologic features may predict the clinical outcome of hepatic graft versus host disease (H-GVHD). Blood , 104 (11) 5079 - ?.

Duarte, RF; Delgado-Gonzalez, J; Shaw, BE; Wrench, D; Ethell, M; Patch, D; ... Quaglia, AF; + view all (2004) Pathologic features may predict the clinical outcome of hepatic graft versus host disease (H-GVHD). In: BLOOD. (pp. 353B - 353B). AMER SOC HEMATOLOGY

Dunham, A; Matthews, LH; Burton, J; Ashurst, JL; Howe, KL; Ashcroft, KJ; ... Ross, MT; + view all (2004) The DNA sequence and analysis of human chromosome 13. NATURE , 428 (6982) 522 - 528. 10.1038/nature02379.

E

Eardley, KS; Ferreriera, MAS; Howie, AJ; Gosling, P; Lipkin, GW; (2004) Urinary albumin excretion: a predictor of glomerular findings in microscopic haematuria. QJM , 97 297 - 301.

Eckhardt, F; Beck, S; Gut, IG; Berlin, K; (2004) Future potential of the human epigenome project. EXPERT REV MOL DIAGN , 4 (5) 609 - 618.

Eguchi, M; Eguchi-Ishimae, M; Green, AR; Enver, T; Greaves, M; (2004) Directing oncogenic fusion genes into stem cells via an SCL enhancer. In: BLOOD. (pp. 66A - 66A). AMER SOC HEMATOLOGY

Ellis, IO; Bartlett, J; Dowsett, M; Humphreys, S; Jasani, B; Miller, K; ... Walker, R; + view all (2004) Updated recommendations for HER2 testing in the UK. J CLIN PATHOL , 57 (3) 233 - 237. 10.1136/jcp.2003.007724.

F

Feber, A; Clark, J; Goodwin, G; Dodson, AR; Smith, PH; Fletcher, A; ... Cooper, CS; + view all (2004) Amplification and overexpression of E2F3 in human bladder cancer. ONCOGENE , 23 (8) 1627 - 1630. 10.1038/sj.onc.1207274.

Feinberg, J; Fieschi, C; Doffinger, R; Feinberg, M; Leclerc, T; Boisson-Dupuis, S; ... Casanova, JL; + view all (2004) Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol , 34 (11) 3276 - 3284. 10.1002/eji.200425221.

Feingold, EA; Good, PJ; Guyer, MS; Kamholz, S; Liefer, L; Wetterstrand, K; ... ENCODE Project Consortium,; + view all (2004) The ENCODE (ENCyclopedia of DNA elements) Project. SCIENCE , 306 (5296) 636 - 640. 10.1126/science.1105136.

Ffolkes, LV; Freeman, A; Harland, SJ; Parkinson, MC; (2004) Are there diagnostic problems with testis tumours? JOURNAL OF PATHOLOGY , 204 35A - 35A.

Flores, L; Henry, J; Bailey, S; Tahberhai, Z; Harris, D; Buchmueller, K; ... Lee, M; + view all (2004) JH-37, a hairpin polyamide, inhibits the binding of nuclear factor-Y to inverted CCAAT boxes in the human topoisomerase II alpha promoter. A biochemical and biophysical study. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U26 - U27). AMER CHEMICAL SOC

Folarin, NI; Baker, RJ; Duke, V; Yogashangary, BC; Vadikolia, C; Wickremasinghe, RG; ... Ganeshaguru, K; + view all (2004) Zap-70 and 19V(H) mutation status in combination with p53 functional analysis identifies the response of poor prognosis B-CLL patients to conventional cytotoxic agents. In: BLOOD. (pp. 527A - 528A). AMER SOC HEMATOLOGY

Forshew, T; Johnson, CA; (2004) SCAMP: a spreadsheet to collate autozygosity mapping projects. J Med Genet , 41 (12) e125 - ?. 10.1136/jmg.2004.023663.

Foster, CS; Falconer, A; Dodson, AR; Norman, AR; Dennis, N; Fletcher, A; ... Cooper, CS; + view all (2004) Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. ONCOGENE , 23 (35) 5871 - 5879. 10.1038/sj.onc.1207800.

Francis, RJ; Mather, SJ; Chester, K; Sharma, SK; Bhatia, J; Pedley, RB; ... Begent, RHJ; + view all (2004) Radiolabelling of glycosylated MFE-23 :: CPG2 fusion protein (MFECP1) with Tc-99m for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT). EUR J NUCL MED MOL I , 31 (8) 1090 - 1096. 10.1007/s00259-004-1474-4.

Freeman, A; Geddes, N; Munson, P; Joseph, J; Ramani, P; Sandison, A; ... Parkinson, MC; + view all (2004) Anaplastic lymphoma kinase (ALK1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. MODERN PATHOL , 17 (7) 765 - 771. 10.1038/modpathol.3800078.

G

Gandini, D; Allen, AJR; Nash, MJ; Linch, DC; Gale, RE; (2004) No mutations in the GATA-1 gene detected in patients with acquired essential thrombocythemia. HAEMATOLOGICA , 89 (5) 613 - 615. Gold open access

Gerrard, G; Butters, TD; Mehta, AB; Hoffbrand, AV; Hughes, D; Burgess, M; Ganeshaguru, K; (2004) Glucosylceramide synthetase inhibitors sensitise B-CLL cells to cytotoxic agents without reversing P-gp functional activity. In: BLOOD. (pp. 334A - 334A). AMER SOC HEMATOLOGY

Gerrard, G; Mitchell, W; Goldstone, A; Chopra, R; Buck, G; Richards, S; Foroni, L; (2004) Sequential quantitative minimal residual disease in BCR-ABL positive acute lymphoblastic leukaemia: Differential observations between major and minor fusion gene rearrangements and variation due to source material. In: BLOOD. (pp. 311A - 311A). AMER SOC HEMATOLOGY

Gerrard, G; Payne, E; Baker, RJ; Jones, DT; Potter, M; Prentice, HG; ... Ganeshaguru, K; + view all (2004) Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. HAEMATOLOGICA , 89 (7) 782 - 790. Gold open access

Gerrard, G; Payne, E; Baker, RJ; Jones, DT; Potter, M; Prentice, HG; ... McCullough, H; + view all (2004) Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. Haematologica , 89 (7) 782 - 790.

Ginhoux, F; Turbant, S; Gross, DA; Poupiot, J; Marais, T; Lone, Y; ... Davoust, J; + view all (2004) HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. Mol Ther , 10 (2) 279 - 289. 10.1016/j.ymthe.2004.05.012.

Gissen, P; Johnson, CA; Morgan, NV; Stapelbroek, JM; Forshew, T; Cooper, WN; ... Maher, ER; + view all (2004) Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome. NAT GENET , 36 (4) 400 - 404. 10.1038/ng1325.

Goyenvalle, A; Vulin, A; Fougerousse, F; Leturcq, F; Kaplan, JC; Garcia, L; Danos, O; (2004) Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science , 306 (5702) 1796 - 1799. 10.1126/science.1104297.

Goyenvalle, A; Vulin, A; Fougerousse, F; Leturcq, F; Kaplan, JC; Garcia, L; Danos, O; (2004) [An opening in Duchenne muscular dystrophy: persistent therapeutic rescue of dystrophin by vectorized antisense mediated exon skipping in mdx mice]. Med Sci (Paris) , 20 (12) 1163 - 1165. 10.1051/medsci/200420121163.

Graff, CP; Chester, K; Begent, R; Wittrup, KD; (2004) Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 degrees C. PROTEIN ENG DES SEL , 17 (4) 293 - 304. 10.1093/protein/gzh038.

Grafone, T; Mancini, M; Ottaviani, E; Renzulli, M; Boschelli, F; Ferraretti, L; ... Martinelli, G; + view all (2004) A novel 4-anilino-3-quinolinecarbonitrile dual sre and AbI kinase inhibitor (SKI-606) has in vitro activity on CML Ph plus Blast cells resistant to imatinib. In: BLOOD. (pp. 549A - 550A). AMER SOC HEMATOLOGY

Grasso, A; Stigliano, R; Morisco, F; Quaglia, A; Dhillon, AP; Davidson, B; ... Burroughs, AK; + view all (2004) Hepatocellular carcinoma treated by orthotopic liver transplantation: Prediction for recurrence. In: JOURNAL OF HEPATOLOGY. (pp. 46 - 46). ELSEVIER SCIENCE BV

Gray, JT; Davidoff, AM; Nathwani, AC; (2004) A novel human factor IX expression cassette packaged as self-complementary DNA dimers in adeno-associated virus vectors results in dramatically improved liver transduction, significantly improving prospects for hemophilia B gene therapy. In: BLOOD. (pp. 869A - 869A). AMER SOC HEMATOLOGY

Green, A; Flynn, A; Pedley, RB; Dearling, J; Begent, R; (2004) Nonuniform absorbed dose distribution in the kidney: The influence of organ architecture. CANCER BIOTHER RADIO , 19 (3) 371 - 377.

Gregson, SJ; Howard, PW; Gullick, DR; Hamaguchi, A; Corcoran, KE; Brooks, NA; ... Thurston, DE; + view all (2004) Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8 ' ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers. J MED CHEM , 47 (5) 1161 - 1174. 10.1021/jm0308971.

Grimwade, D; Enver, T; (2004) Acute promyelocytic leukemia: where does it stem from? LEUKEMIA , 18 (3) 375 - 384. 10.1038/sj.leu.2403234.

Grimwade, D; Gale, R; Hills, R; Kottaridis, P; Swirsky, D; Gilkes, A; ... NCRI Adult Leukaemia Working Party,; + view all (2004) The relationship between FLT3 mutation status, biological characteristics and outcome in patients with acute promyelocytic leukaemia. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 69 - 69). BLACKWELL PUBLISHING LTD

Guinn, BA; Gilkes, AF; Mufti, GJ; Linch, D; Burnett, AK; Mills, KI; (2004) Use of cDNA microarray analysis to identify cancer testes antigen expression in presentation acute myeloid leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 125 51 - ?.

H

Harney, J; Shah, N; Short, S; Daley, F; Groom, N; Wilson, GD; ... Saunders, MI; + view all (2004) The evaluation of low dose hyper-radiosensitivity in normal human skin. Radiotherapy and Oncology , 70 (3) 319 - 329. 10.1016/j.radonc.2004.01.015.

Harney, J; Short, S; Shah, N; Joiner, M; Saunders, MI; (2004) Low dose hyper-radiosensitivity in metastatic tumors. International Journal of Radiation Oncology Biology Physics , 59 (4) 1190 - 1195. 10.1016/j.ijrobp.2003.12.029.

Hartley, JA; (2004) Assessing individual responses to anti-cancer therapy using the comet assay. MUTAGENESIS , 19 (6) 504 - 504.

Hartley, JA; Spanswick, VJ; Brooks, N; Clingen, PH; McHugh, PJ; Hochhauser, D; ... Thurston, DE; + view all (2004) SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 1: Cellular pharmacology, in vitro and initial in vivo antitumor activity. CANCER RES , 64 (18) 6693 - 6699.

Hartley, JA; Spanswick, VJ; Brooks, N; Clingen, PH; McHugh, PJ; Hochhauser, D; ... Thurston, DE; + view all (2004) SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity. Cancer Res , 64 (18) 6693 - 6699. 10.1158/0008-5472.CAN-03-2941.

Haynes, SVZ; Dudderidge, TJ; (2004) Emergency contraception: the journey so far. BJOG-INT J OBSTET GY , 111 (1) 91 - 91. 10.1046/j.1471-5028.2003.00020.x.

Henry, JA; Le, NM; Nguyen, B; Howard, CM; Bailey, SL; Horick, SM; ... Lee, M; + view all (2004) Targeting the inverted CCAAT box 2 in the topoisomerase II alpha promoter by JH-37, an imidazole-pyrrole polyamide hairpin: Design, synthesis, molecular biology, and biophysical studies. BIOCHEMISTRY-US , 43 (38) 12249 - 12257. 10.1021/bi048785z.

Herrero, J; Vaquerizas, JM; Al-Shahrour, F; Conde, L; Mateos, A; Díaz-Uriarte, JS; Dopazo, J; (2004) New challenges in gene expression data analysis and the extended GEPAS. Nucleic Acids Res , 32 (Web Server issue) W485 - W491. 10.1093/nar/gkh421.

Hewison, M; Zehnder, D; Chakraverty, R; Adams, JS; (2004) Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. MOLECULAR AND CELLULAR ENDOCRINOLOGY , 215 (1-2) 31 - 38. 10.1016/j.mce.2003.11.017.

Horton, R; Wilming, L; Rand, V; Lovering, RC; Bruford, EA; Khodiyar, VK; ... Beck, S; + view all (2004) Gene map of the extended human MHC. NAT REV GENET , 5 (12) 889 - 899. 10.1038/nrg1489.

Hoskin, PJ; (2004) The RIB trial. Clinical Oncology , 16 (7) 445 - 446.

Hoskin, PJ; Decanha, SM; P, G-J; R,; (2004) High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma. Radiotherapy and Oncology , 73 195 - 198.

Hoskin, PJ; Sibtain, A; Daley, FM; Saunders, MI; Wilson, GD; (2004) The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma. Radiotherapy and Oncology , 72 (2) 159 - 168.

Howie, AJ; Ferreira, MAS; Lipkin, GW; Adu, D; (2004) Measurement of chronic damage in the donor kidney and graft survival. Transplantation , 77 1058 - 1065. 10.1097/01.TP.0000120177.44144.FF.

Hubbard, T; Andrews, D; Caccamo, M; Cameron, G; Chen, Y; Clamp, M; ... Birney, E; + view all (2004) Ensembl 2005. Nucleic Acids Research , 33 (Database issue) D447 - D453. 10.1093/nar/gki138.

Hughes, DA; Baker, RJ; Richfield, L; Milligan, A; Bruce, R; Mehta, AB; (2004) Balanced oral substrate reduction therapy for patients with mild to moderate Gaucher's disease: Initial results in clinical practice. In: BLOOD. (pp. 41B - 42B). AMER SOC HEMATOLOGY

Hughes, DA; Duke, VM; Baker, RJ; Wright, F; Foroni, L; Atul, MB; (2004) High prevalence of B-cell clonality in patients with Gaucher's disease. In: BLOOD. (pp. 657A - 657A). AMER SOC HEMATOLOGY

Hughes, DA; Li, A; Keshav, S; Mehta, A; (2004) Hepcidin dysregulation in patients with type 1 Gaucher's disease. In: BLOOD. (pp. 42B - 43B). AMER SOC HEMATOLOGY

Hughes, DA; Mehta, AB; (2004) Abnormal distribution of cell surface receptors in glycosphingolipid storage disorders: an in vitro model of Gaucher's and Fabry disease. BRITISH JOURNAL OF HAEMATOLOGY , 125 59 - 59.

Hughes, DA; Stuart-Smith, SE; Bain, BJ; (2004) How should stainable iron in bone marrow films be assessed? J Clin Pathol , 57 (10) 1038 - 1040. 10.1136/jcp.2003.015834.

Hughes, SE; (2004) The pathology of hypertrophic cardiomyopathy. Histopathology , 44 412 - 427.

Huhalov, A; Chester, KA; (2004) Engineered single chain antibody fragments for radioimmunotherapy. Q J Nucl Med Mol Imaging , 48 (4) 279 - 288.

Huhalov, A; Graff, C; Wittrup, KD; Tolner, B; Pedley, RB; Vervecken, W; ... Chester, KA; + view all (2004) HSAbodies: A new class of engineered antibody-based molecules for targeting cancer. BRITISH JOURNAL OF CANCER , 91 S63 - S63.

Humphray, SJ; Oliver, K; Hunt, AR; Plumb, RW; Loveland, JE; Howe, KL; ... Dunham, I; + view all (2004) DNA sequence and analysis of human chromosome 9. NATURE , 429 (6990) 369 - 374. 10.1038/nature02465.

I

Irshad, S; Pedley, RB; Anderson, J; Latchman, DS; Budhram-Mahadeo, V; (2004) The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. J BIOL CHEM , 279 (20) 21617 - 21627. 10.1074/jbc.M312506200. Gold open access

Israeli, D; Benchaouir, R; Ziaei, S; Rameau, P; Gruszczynski, C; Peltekian, E; ... Garcia, L; + view all (2004) FGF6 mediated expansion of a resident subset of cells with SP phenotype in the C2C12 myogenic line. J Cell Physiol , 201 (3) 409 - 419. 10.1002/jcp.20088.

J

Jakupovic, I; Grandage, VL; Linch, DC; Khwaja, A; (2004) Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells. BLOOD , 103 (8) 3230 - 3232.

Janciauskiene, S; Eriksson, S; Callea, F; Mallya, M; Zhou, A; Seyama, K; ... Lomas, DA; + view all (2004) Differential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of alpha1-antitrypsin. Hepatology , 40 (5) 1203 - 1210. 10.1002/hep.20451.

Jennings, BH; Shah, S; Yamaguchi, Y; Seki, M; Phillips, RG; Handa, H; Ish-Horowicz, D; (2004) Locus-specific requirements for Spt5 in transcriptional activation and repression in Drosophila. Curr Biol , 14 (18) 1680 - 1684. 10.1016/j.cub.2004.08.066.

Jennings, I; Mackie, I; Arnout, J; Preston, FE; UK Natl External Quality,; (2004) Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: performance in the UKNEQAS proficiency testing programme. J THROMB HAEMOST , 2 (12) 2178 - 2184.

Jones, C; Mackay, A; Grigoriadis, A; Cossu, A; Reis-Filho, JS; Fulford, L; ... Lakhani, SR; + view all (2004) Expression profiling of purified normal human luminal and myoepithelial breast cells: Identification of novel prognostic markers for breast cancer. CANCER RES , 64 (9) 3037 - 3045.

Jones, DT; Addison, E; North, JM; Lowdell, MW; Hoffbrand, AV; Mehta, AB; ... Wickremasinghe, RG; + view all (2004) Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. BLOOD , 103 (5) 1855 - 1861. 10.1182/blood-2003-05-1603.

Jones, DT; Addison, E; North, JM; Lowdell, MW; Hoffbrand, AV; Mehta, AB; ... Wickremasinghe, RG; + view all (2004) Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. Blood , 103 (5) 1855 - 1861. 10.1182/blood-2003-05-1603. Green open access
file

K

Keeling, DM; Mackie, IJ; Moody, A; Watson, HG; Haemostasis Thrombosis Task Force,; Brit Comm Standards Haematology,; (2004) The diagnosis of deep vein thrombosis in symptomatic outpatients and the potential for clinical assessment and D-dimer assays to reduce the need for diagnostic imaging. BRIT J HAEMATOL , 124 (1) 15 - 25.

Kemp, Z; Thirlwell, C; Sieber, O; Silver, A; Tomlinson, I; (2004) An update on the genetics of colorectal cancer. HUM MOL GENET , 13 R177 - R185. 10.1093/hmg/ddh247.

Kooistra, K; Zhang, YH; Henriquez, NV; Weiss, B; Mumberg, D; Noteborn, MH; (2004) TT virus-derived apoptosis-inducing protein induces apoptosis preferentially in hepatocellular carcinoma-derived cells. 1445 - 1450.

Kroeger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; ... Marks, D; + view all (2004) Comparison between anti-thymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch in melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated stem cell transplantation in patients with multiple myeloma. In: BLOOD. (pp. 280A - 281A). AMER SOC HEMATOLOGY

Kroger, N; Thomson, K; Zabelina, T; Peggs, K; Chopra, R; Shimoni, A; ... German Cooperative Transplant Grp,; + view all (2004) Comparison between anti-thymocyte globulin and alemtuzumab as part of the melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated stem cell transplantation in patients with lymphoid malignancies. In: BONE MARROW TRANSPLANTATION. (pp. S11 - S11). NATURE PUBLISHING GROUP

Kupchinsky, S; Centioni, S; Howard, T; Trzupek, J; Roller, S; Carnahan, V; ... Lee, M; + view all (2004) A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties. BIOORGAN MED CHEM , 12 (23) 6221 - 6236.

Kyriakou, CA; Goldstone, AH; Sureda, A; Yong, K; D'Sa, S; Taghipour, G; ... Schmitz, N; + view all (2004) Patients with lymphoplasmacytic lymphoma can be salvaged with autologous stem cell transplantation, irrespectively of the number of previous treatment lines. Analysis of 146 cases from the European Bone Marrow Transplant Registry (EBMT). In: BLOOD. (pp. 7A - 7A). AMER SOC HEMATOLOGY

Kyriakou, CA; Goldstone, AH; Sureda, A; Yong, K; Taghipour, G; de Elvira, CR; ... Schmitz, N; + view all (2004) Role of allogeneic stem cell transplantation in lymphoplasmacytic lymphoma. Analysis of 61 cases from the European Bone Marrow Registry (EBMT). In: BLOOD. (pp. 909A - 909A). AMER SOC HEMATOLOGY

L

Lacy, ER; Nguyen, B; Le, M; Cox, KK; O'Hare, C; Hartley, JA; ... Wilson, WD; + view all (2004) Energetic basis for selective recognition of T center dot G mismatched base pairs in DNA by imidazole-rich polyamides. NUCLEIC ACIDS RES , 32 (6) 2000 - 2007. 10.1093/nar/gkh515. Gold open access

Lajmi, AR; Sleep, S; Ng, C; Zhou, JF; Spence, YY; Davidoff, AM; Nathwani, AC; (2004) Scaleable membrane chromatography purification method for adeno-associated viral vectors. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U237 - U237). AMER CHEMICAL SOC

Landreau, CAS; LePla, RC; Shipman, M; Slawin, AMZ; Hartley, JA; (2004) Delineating noncovalent interactions between the azinomycins and double-stranded DNA: Importance of the naphthalene substitution pattern on interstrand cross-linking efficiency. ORG LETT , 6 (20) 3505 - 3507. 10.1021/ol048653y.

Lankester, KJ; Maxwell, RJ; Pedley, RB; Hill, SA; Rustin, GJS; Tozer, GM; (2004) Acute anti-vascular effects of combretastatin A4 phosphate (CA-4-P) on the SW1222 tumour as measured by dynamic contrast enhanced (DCE)-MRI. BRITISH JOURNAL OF CANCER , 91 S16 - S16.

Laurence, A; Marin, D; Clark, R; Shepherd, P; Mackinnon, S; (2004) Frequency of blast crisis after achieving complete cytogenetic remission in first chronic phase CML patients who recieved imatinib therapy within six months of diagnosis. In: BLOOD. (pp. 292A - 292A). AMER SOC HEMATOLOGY

Le Pla, RC; Landreau, CAS; Shipman, M; Slawin, AMZ; Hartley, JA; (2004) The role of the naphthoate moiety and its substituents upon the efficiency of DNA interstrand cross-linking by the azinomycins. MUTAGENESIS , 19 (6) 516 - 516.

Ledermann, JA; Wheeler, S; (2004) How should we manage patients with "platinum-sensitive" recurrent ovarian cancer? CANCER INVEST , 22 2 - 10. 10.1081/CNV-200030117.

Leonard, RC; Lind, M; Twelves, C; Coleman, R; van Belle, S; Wilson, C; ... Anglo-Celtic Cooperative Oncology Group,; + view all (2004) Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial. J Natl Cancer Inst , 96 (14) 1076 - 1083. 10.1093/jnci/djh188.

Leonard, RCF; Lind, M; Twelves, C; Coleman, R; van Belle, S; Wilson, C; ... Anglo-Celtic Cooperative Oncology,; + view all (2004) Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: A randomized trial. J NATL CANCER I , 96 (14) 1076 - 1083.

Lomas, DA; (2004) Lung volume reduction surgery: where are we now? Chron Respir Dis , 1 (1) 2 - 4.

Lomas, DA; Belorgey, D; Mallya, M; Onda, M; Kinghorn, KJ; Sharp, LK; ... Miranda, E; + view all (2004) Polymerisation underlies alpha1-antitrypsin deficiency, dementia and other serpinopathies. Front Biosci , 9 2873 - 2891.

Lomas, DA; Parfrey, H; (2004) Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology. Thorax , 59 (6) 529 - 535.

Lowe, GDO; Rumley, A; Mackie, IJ; (2004) Plasma fibrinogen. ANN CLIN BIOCHEM , 41 430 - 440.

M

Maccioni, RB; Lavados, M; Maccioni, CB; Mendoza-Naranjo, A; (2004) Biological markers of Alzheimer's disease and mild cognitive impairment. Curr Alzheimer Res , 1 (4) 307 - 314.

MacGregor, A; Hackshaw, A; (2004) Prevalence of migraine on each day of the natural menstrual cycle. Neurology , 63 351 - 353.

Mackie, I; Yarranton, H; Machin, S; Pinkoski, L; Corash, L; (2004) Von Willebrand factor cleaving protease is retained in intercept plasma. In: TRANSFUSION. (pp. 102A - 102A). BLACKWELL PUBLISHING INC

Mackie, IJ; de Laat, HB; Purdy, G; Adam, M; Woodhams, B; Derksen, RHWM; de Groot, PG; (2004) A prototype commercial ELISA for protein S antibodies. In: THROMBOSIS RESEARCH. (pp. 639 - 639). PERGAMON-ELSEVIER SCIENCE LTD

Marafioti, T; Mancini, C; Ascani, S; Sabattini, E; Zinzani, PL; Pozzobon, M; ... Pileri, SA; + view all (2004) Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease. Haematologica , 89 (8) 957 - 964.

Marafioti, T; Pozzobon, M; Hansmann, ML; Delsol, G; Pileri, SA; Mason, DY; (2004) Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood , 103 (1) 188 - 193. 10.1182/blood-2003-05-1487.

Marotta, R; Chin, J; Quigley, A; Katsabanis, S; Kapsa, R; Byrne, E; Collins, S; (2004) Diagnostic screening of mitochondrial DNA mutations in Australian adults 1990-2001. Internal Medicine Journal , 34 (1-2) 10 - 19.

Martineau, Y; Le Bec, C; Monbrun, L; Allo, V; Chiu, IM; Danos, O; ... Prats, AC; + view all (2004) Internal ribosome entry site structural motifs conserved among mammalian fibroblast growth factor 1 alternatively spliced mRNAs. Mol Cell Biol , 24 (17) 7622 - 7635. 10.1128/MCB.24.17.7622-7635.2004.

Martinelli, G; Martelli, AM; Grafone, T; Rosti, G; Mantovani, I; Cappellini, A; ... Baccarani, M; + view all (2004) A new abl kinase inhibitor (AMN107) has in vitro activity on CML Ph plus Blast cells resistant to imatinib. In: BLOOD. (pp. 255B - 255B). AMER SOC HEMATOLOGY

Martins, LM; Morrison, A; Klupsch, K; Fedele, V; Moisoi, N; Teismann, P; ... Downward, J; + view all (2004) Neuroprotective role of the reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. MOL CELL BIOL , 24 (22) 9848 - 9862. 10.1128/MCB.24.22.9848-9862.2004.

Masir, N; Jones, M; Pozzobon, M; Marafioti, T; Volkova, OY; Mechetina, LV; ... Mason, DY; + view all (2004) Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells. Br J Haematol , 127 (3) 335 - 343. 10.1111/j.1365-2141.2004.05193.x.

Mathias, MC; Mackie, I; Khair, K; Machin, SJ; Liesner, R; (2004) Defective fibrinolysis in children with severe haemophilia A. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 45 - 45). BLACKWELL PUBLISHING LTD

McCann, S; Byrne, JL; Rovira, M; Shaw, P; Ribaud, P; Sica, S; ... Cordonnier, C; + view all (2004) Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. BONE MARROW TRANSPLANTATION , 33 (5) 519 - 529.

McGonigle, GJ; Glasow, A; Grier, DG; Enver, T; Zelent, A; Lappin, TRJ; Thompson, A; (2004) Regulation of Hox genes by IL-3 in 32D and FDCP-mix cells. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 38 - 38). BLACKWELL PUBLISHING LTD

McGurk, CJ; Cummings, M; Hartley, JA; Masters, JR; (2004) Translational regulation of ERCC1 in human cancer cell lines. Proceedings of the American Association for Cancer Research , 45 2631 - ?.

McStay, MK; Khan, K; Savage, K; Stubbs, M; Dhillon, AP; Caplin, M; (2004) Neuroendocrine-like differentiation in hepatocellular and pancreatic cancers. In: GASTROENTEROLOGY. (pp. A494 - A494). W B SAUNDERS CO

McTiernan, A; Whelan, JS; (2004) A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma. Sarcoma , 8 (2-3) 71 - 76. 10.1080/13577140410001711764. Gold open access

Medzihradszky, KF; Spencer, DIR; Sharma, SK; Bhatia, J; Pedley, RB; Read, DA; ... Chester, KA; + view all (2004) Glycoforms obtained by expression in Pichia pastoris improve cancer targeting potential of a recombinant antibody-enzyme fusion protein. GLYCOBIOLOGY , 14 (1) 27 - 37. 10.1093/glycob/cwh001.

Mehta, A; Beck, M; Ricci, R; Widmer, U; (2004) Fabry disease defined: authors' reply. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 (6) 450 - 450.

Mehta, A; Beck, M; Ricci, R; Widmer, U; Sunder-Plassmann, G; (2004) Fabry outcome survey: need for documentation of dermatological, ophthalmologic and psychiatric affections: authors' reply. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 (7) 517 - 517.

Mehta, A; Ricci, R; Widmer, U; Dehout, F; Garcia, D; Kampmann, C; ... Beck, M; + view all (2004) Fabry disease defined: Baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 (3) 236 - 242.

Meja, KK; Catley, MC; Cambridge, LM; Barnes, PJ; Lum, H; Newton, R; Giembycz, MA; (2004) Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89. J Pharmacol Exp Ther , 309 (2) 833 - 844. 10.1124/jpet.103.060020.

Miranda, E; Römisch, K; Lomas, DA; (2004) Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulum. J Biol Chem , 279 (27) 28283 - 28291. 10.1074/jbc.M313166200. Gold open access

Moroncini, G; Kanu, N; Solforosi, L; Abalos, G; Telling, GC; Head, M; ... Williamson, RA; + view all (2004) Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc. P NATL ACAD SCI USA , 101 (28) 10404 - 10409. 10.1073/pnas.0403522101.

Morris, E; Thomson, K; Craddock, C; Milligan, D; Smith, G; Parker, A; ... Mackinnon, S; + view all (2004) Long-term follow-up of an alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant (RIT) regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 29 - 29). BLACKWELL PUBLISHING LTD

Murch, SH; Anthony, A; Casson, DH; Malik, M; Berelowitz, M; Dhillon, AP; ... Walker-Smith, JA; + view all (2004) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children (Retraction of vol 351, pg 637, 1998). LANCET , 363 (9411) 750 - 750.

Murch, SH; Anthony, A; Casson, DH; Malik, M; Berelowitz, M; Dhillon, AP; ... Walker-Smith, JA; + view all (2004) Retraction of an interpretation. Lancet , 363 (9411) 750 - ?. 10.1016/S0140-6736(04)15715-2.

Murphy, RT; Mogensen, J; Shaw, A; Kubo, T; Hughes, S; McKenna, WJ; (2004) Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. The Lancet , 363 (9406) 371 - 372. 10.1016/S0140-6736(04)15468-8.

N

Nacheva, E; Brazma, D; Grace, C; (2004) The genetic profile of CML-new revelations with matrix CGH. In: BLOOD. (pp. 805A - 806A).

Narat, S; Folarin, NI; Baker, RJ; Duke, V; Yogashangary, BC; Jones, DT; ... Ganeshaguru, K; + view all (2004) The role of multidrug resistance proteins and drug sensitivity in relation to poor prognosis identified by ZAP-70 expression and IgV(H) mutation status in B-CLL. In: BLOOD. (pp. 281B - 281B). AMER SOC HEMATOLOGY

Nash, MJ; Camilleri, RS; Everington, T; Cohen, H; (2004) An analysis of the antiphospholipid antibody status of 111 women with late pregnancy morbidity. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 48 - 49). BLACKWELL PUBLISHING LTD

Nash, MJ; Camilleri, RS; Kunka, S; Mackie, IJ; Machin, SJ; Cohen, H; (2004) The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 2 (7) 1077 - 1081.

Nash, MJ; Camilleri, RS; Mackie, IJ; Machin, SJ; Cohen, H; (2004) An analysis of the beta(2)-glycoprotein I Cys306Gly polymorphism in patients with thrombotic and obstetric disorders. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 48 - 48). BLACKWELL PUBLISHING LTD

Nash, MJ; Cohen, H; (2004) Management of Jehovah's Witness patients with haematological problems. BLOOD REV , 18 (3) 211 - 217. 10.1016/S0268-960X(03)00065-1.

Nash, MJ; Mackie, IJ; Cohen, H; Machin, SJ; (2004) Antiphospholipid antibodies can reduce the in vitro cleavage of domain V of beta2-glycoprotein I by plasmin. In: THROMBOSIS RESEARCH. (pp. 616 - 616). PERGAMON-ELSEVIER SCIENCE LTD

Nash, MJ; Mackie, IJ; Machin, SJ; (2004) Kallikrein is able to specifically cleave beta2-glycoprotein I in domain V. In: THROMBOSIS RESEARCH. (pp. 620 - 620). PERGAMON-ELSEVIER SCIENCE LTD

Nathwani, AC; Benjamin, R; Nienhuis, AW; Davidoff, AM; (2004) Current status and prospects for gene therapy. VOX SANG , 87 (2) 73 - 81.

Nathwani, AC; Davidoff, AM; Tuddenham, EGD; (2004) Prospects for gene therapy of haemophilia. HAEMOPHILIA , 10 (4) 309 - 318. 10.1111/j.1365-2516.2004.00926.x.

Newsom-Davis, T; Bower, M; Wildfire, A; Thirlwell, C; Nelson, M; Gazzard, B; Stebbing, J; (2004) Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levels. LEUKEMIA LYMPHOMA , 45 (9) 1939 - 1941. 10.1080/10428190410001693533.

Nicholls, BM; Bredius, R; Nesbitt, SA; Horton, MA; Flanagan, AM; (2004) Limited evidence of rescue of osteoclast-poor osteopetrosis following successful engraftment by cord blood from an unrelated donor. In: JOURNAL OF BONE AND MINERAL RESEARCH. (pp. 1034 - 1034). AMER SOC BONE & MINERAL RES

Nicholls, BM; Bredius, RG; Nesbitt, SA; Horton, MA; Flanagan, AM; (2004) LITTLE EVIDENCE OF RESCUE OF OSTEOCLAST-POOR OSTEOPETROSIS FOLLOWING 'SUCCESSFUL ENGRAFTMENT' BY CORD BLOOD FROM AN UNRELATED DONOR. CALCIFIED TISSUE INT , 74 S64 - S64.

Nivsarkar, MS; Nathwani, A; Mosley, K; Davies, N; Gregory, LG; David, AL; ... Waddington, SN; + view all (2004) Testosterone induced increase in transgene expression in vivo using Adenoviral Gene Delivery Vectors. Presented at: 1st Annual Conference of the British-Society-for-Gene-Therapy, Keble Coll, Oxford, ENGLAND.

Nobles, M; Higgins, CF; Sardini, A; (2004) Extracellular acidification elicits a chloride current that shares characteristics with I-Cl((swell)). AM J PHYSIOL-CELL PH , 287 (5) C1426 - C1435. 10.1152/ajpcell.00549.2002.

O

O'Connell, NM; McIntosh, JH; Riddell, A; Pascoe, G; Griffioen, A; Lee, CA; Perry, DJ; (2004) Thrombin generation and correlation with bleeding tendency in inherited FXI deficiency. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 44 - 44). BLACKWELL PUBLISHING LTD

Okkenhaug, K; Bilancio, A; Emery, JL; Vanhaesebroeck, B; (2004) Phosphoinositide 3-kinase in T cell activation and survival. Biochem Soc Trans , 32 (Pt 2) 332 - 335.

P

Parfrey, H; Dafforn, TR; Belorgey, D; Lomas, DA; Mahadeva, R; (2004) Inhibiting polymerization - New therapeutic strategies for z alpha(1)-antitrypsin-related emphysema. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY , 31 (2) 133 - 139. 10.1165/rdmb.2003-0276OC.

Parfrey, H; Dafforn, TR; Belorgey, D; Lomas, DA; Mahadeva, R; (2004) Inhibiting polymerization: new therapeutic strategies for Z alpha1-antitrypsin-related emphysema. Am J Respir Cell Mol Biol , 31 (2) 133 - 139. 10.1165/rcmb.2003-0276OC.

Parker, LL; Lacy, SM; Farrugia, LJ; Evans, C; Robins, DJ; O'Hare, CC; ... Stratford, IJ; + view all (2004) A novel design strategy for stable metal complexes of nitrogen mustards as bioreductive prodrugs. J MED CHEM , 47 (23) 5683 - 5689. 10.1021/jm0449866w.

Parsonnet, J; Isaacson, PG; (2004) Bacterial infection and MALT lymphoma. The New England Journal of Medicine , 350 213 - 215. 10.1056/NEJMp038200. Green open access
file

Patel, BD; Loo, WJ; Tasker, AD; Screaton, NJ; Burrows, NP; Lomas, DA; (2004) Premature facial wrinkling is an external marker of smoking-related chronic obstructive pulmonary disease. In: BRITISH JOURNAL OF DERMATOLOGY. (pp. 9 - 9).

Patel, BD; Luben, RN; Welch, AA; Bingham, SA; Khaw, KT; Day, NE; ... Wareham, NJ; + view all (2004) Childhood smoking is an independent risk factor for obstructive airways disease in women. Thorax , 59 (8) 682 - 686. 10.1136/thx.2003.010215.

Pedley, RB; Sharma, SK; Hawkins, RE; Chester, KA; (2004) Antibody-directed enzyme-prodrug therapy. In: UNSPECIFIED (491 - 514).

Peggs, K; (2004) Imatinib mesylate - gold standards and silver linings. CLIN EXP MED , 4 (1) 1 - 9. 10.1007/s10238-004-0032-5.

Peggs, K; Mackinnon, S; (2004) Graft-versus-myeloma: are durable responses a clinical reality following donor lymphocyte infusion? LEUKEMIA , 18 (9) 1541 - 1542. 10.1038/sj.leu.2403432.

Peggs, K; Mackinnon, S; Ayuk, FA; Zander, AR; Kröger, N; (2004) Graft-versus-myeloma: Are durable responses a clinical reality following donor lymphocyte infusion? (multiple letters) (2). Leukemia , 18 (9) 1541 - 1543.

Peggs, KS; (2004) Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy. Expert Rev Anti Infect Ther , 2 (4) 559 - 573.

Peggs, KS; (2004) Immune reconstitution following stem cell transplantation. LEUKEMIA LYMPHOMA , 45 (6) 1093 - 1101. 10.1080/10428190310001641260.

Peggs, KS; (2004) Role of MabCampath in allogeneic transplantation. Ann Hematol , 83 Suppl 1 S66 - S68. 10.1007/s00277-004-0850-2.

Peggs, KS; Mackinnon, S; (2004) Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-Cell therapy. HUM IMMUNOL , 65 (5) 550 - 557. 10.1016/j.humimm.2004.02.016.

Peggs, KS; Mackinnon, S; (2004) Cytomegalovirus: the role of CMV post-haematopoietic stem cell transplantation. INT J BIOCHEM CELL B , 36 (4) 695 - 701. 10.1016/j.biocel.2003.08.008.

Peggs, KS; Mackinnon, S; (2004) Immune reconstitution following haematopoietic stem cell transplantation. BRIT J HAEMATOL , 124 (4) 407 - 420. 10.1046/j.1365-2141.2003.04767.x.

Peggs, KS; Sureda, A; Hunter, A; Caballero, MD; Cavet, J; Urbano-Ispizua, A; ... Mackinnon, S; + view all (2004) Impact of in vivo T-cell depletion on outcome following reduced intensity transplantation for Hodgkin lymphoma: Comparison between 2 prospective studies. In: BLOOD. (pp. 230A - 230A). AMER SOC HEMATOLOGY

Peggs, KS; Thomson, K; Hunter, A; Chopra, R; Mahendra, P; Milligan, D; ... Mackinnon, S; + view all (2004) Exploiting alloreactivity in relapsed and refractory Hodgkin Lymphoma: long-term follow-up of a T-cell-depleted reduced intensity transplant protocol. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 3 - 4). BLACKWELL PUBLISHING LTD

Peggs, KS; Verfuerth, S; Chow, C; Thomson, K; Goldstone, AH; Linch, DC; Mackinnon, S; (2004) Adoptive cellular therapy for cytomegalovirus following allogeneic stem cell transplantation: Toxicity and efficacy. In: BLOOD. (pp. 59A - 59A). AMER SOC HEMATOLOGY

Peggs, KS; Verfuerth, S; Pizzy, A; Khan, N; Guiver, M; Moss, PA; Mackinnon, S; (2004) Adoptive cellular therapy for early cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T-cell lines. BLOOD CELLS MOLECULES AND DISEASES , 33 (3) 198 - 199.

Peltenburg, LT; de Bruin, EC; Meersma, D; Wilting, S; Jürgensmeier, JM; Schrier, PI; (2004) c-Myc is able to sensitize human melanoma cells to diverse apoptotic triggers. Melanoma Res , 14 (1) 3 - 12.

Pereira, JJ; Docherty, SE; Price, JT; Thompson, EW; Reid, HH; Rossjohn, J; ... Marshall, J; + view all (2004) Bimolecular Interaction of Insulin-Like Growth Factor (IGF) Binding Protein-2 with αvβ3 Negatively Modulates IGF-I-Mediated Migration and Tumor Growth. Cancer Research , 64 (3) 977 - 984. 10.1158/0008-5472.CAN-03-3056.

Perez, N; Bigey, P; Scherman, D; Danos, O; Piechaczyk, M; Pelegrin, M; (2004) Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation. Genet Vaccines Ther , 2 (1) 2 - ?. 10.1186/1479-0556-2-2. Gold open access

Pileri, SA; Sabattini, E; Agostinelli, C; Bodega, L; Rossi, M; Zinzani, PL; Marafioti, T; (2004) Histopathology of B-cell chronic lymphocytic leukemia. In: UNSPECIFIED (807 - viii).

Poerio, A; Amabile, M; Soverini, S; Renzulli, M; Rosti, G; Bassi, S; ... Martinelli, G; + view all (2004) Down regulation of TOPK, PBX3, SRPK, DDX21 and CLC genes in newly diagnosed, early-chronic phase chronic myeloid leukemia patients treated with imatinib mesylate. In: BLOOD. (pp. 246B - 246B). AMER SOC HEMATOLOGY

Porakishvili, N; Kulikova, N; Manoussaka, M; Jewell, AP; Youinou, PY; Nedelec, S; ... Lydyard, PM; + view all (2004) Differential expression of CD180 and sIgM by B chronic lymphocytic leukaemia cells (B-CLL) using mutated and unmutated IgVh genes. In: BLOOD. (pp. 768A - 768A). AMER SOC HEMATOLOGY

Porakishvili, N; Manoussaka, M; Kulikova, N; Walton, J; Nathwani, A; Jewell, AP; ... Lydyard, PM; + view all (2004) Activation and proliferation of B cell chronic lymphocytic leukaemia (B-CLL) cells through anti-CD180, Anti-CD40 and IL-4. In: BLOOD. (pp. 277B - 277B). AMER SOC HEMATOLOGY

Pors, K; Paniwnyk, Z; Ruparelia, KC; Teesdale-Spittle, PH; Hartley, JA; Kelland, LR; Patterson, LH; (2004) Synthesis and biological evaluation of novel chloroethylaminoanthraquinones with potent cytotoxic activity against cisplatin-resistant tumor. J MED CHEM , 47 (7) 1856 - 1859. 10.1021/jm031070u.

Pozzobon, M; Marafioti, T; Hansmann, ML; Natkunam, Y; Mason, DY; (2004) Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples. Br J Haematol , 124 (4) 519 - 533.

Preston, SL; Oukrif, D; Kyriakides, A; Elia, G; Novelli, M; Direkze, N; ... Wright, NA; + view all (2004) Modes of growth of colorectal adenomas (flat and polypoid): Evidence against 'top-down' as a major method of expansion. In: JOURNAL OF PATHOLOGY. (pp. 11A - 11A). JOHN WILEY & SONS LTD

Preston, SL; Oukrif, D; Kyriakides, A; Elia, G; Novelli, M; Direkze, NC; ... Wright, NA; + view all (2004) Flat adenomas in the colon originate in monocryptal adenomas and clonally expand by superficial budding without significant "top down" spread. In: GUT. (pp. A20 - A20). B M J PUBLISHING GROUP

Preston, SL; Oukrif, D; Kyriakides, A; Elia, G; Talbot, IC; Tomlinson, IP; ... Wright, NA; + view all (2004) Patterns of beta-catenin staining and downstream targets of beta-catenin/TCF/LEF transcription reveal modes of growth of colorectal adenomas: Evidence against "top down" as a major component of clonal expansion. In: GUT. (pp. A29 - A29). B M J PUBLISHING GROUP

Preston, SL; Oukrif, D; Kyriakides, E; Elia, G; Talbot, IC; Tomlinson, IP; ... Wright, NA; + view all (2004) Patterns of beta-catenin staining and downstream targets of beta-catenin/Tcf/Lef transcription reveal modes of growth of colorectal adenomas: evidence against 'top-down' as a major component of clonal expansion. In: GASTROENTEROLOGY. (pp. A135 - A135). W B SAUNDERS CO

Q

Quezada, SA; Jarvinen, LZ; Lind, EE; Noelle, RJ; (2004) CD40/CD154 interactions at the interface of tolerance and immunity. ANNU REV IMMUNOL , 22 307 - 328. 10.1146/annurev.immunol.22.012703.104533.

R

Rakyan, VK; Hildmann, T; Novik, KL; Lewin, J; Tost, J; Cox, AV; ... Beck, S; + view all (2004) DNA methylation profiling of the human major histocompatibility complex: A pilot study for the Human Epigenome Project. PLOS BIOL , 2 (12) , Article e405. 10.1371/journal.pbio.0020405. Green open access
file

Raslova, H; Komura, E; Le Couédic, JP; Larbret, F; Debili, N; Feunteun, J; ... Favier, R; + view all (2004) FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest , 114 (1) 77 - 84. 10.1172/JCI21197.

Ravichandran, D; Kocjan, G; Falzon, M; Ball, RY; Ralphs, DNL; (2004) Imprint cytology of the sentinel lymph node in the assessment of axillary node status in breast carcinoma. EJSO , 30 (3) 238 - 242. 10.1016/j.ejso.2003.11.005.

Reid, AG; Nacheva, EP; (2004) A potential role for PRDM12 in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion. In: LEUKEMIA. (pp. 178 - 180). NATURE PUBLISHING GROUP

Reif, K; Okkenhaug, K; Sasaki, T; Penninger, JM; Vanhaesebroeck, B; Cyster, JG; (2004) Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol , 173 (4) 2236 - 2240.

Revell, PA; Damien, E; Zhang, XS; Evans, P; Howlett, CR; (2004) The effect of magnesium ions on bone bonding to hydroxyapatite coating on titanium alloy implants. BIOCERAMICS, VOL 16 , 254-2 447 - 450.

Roberts, I; Foster, N; Nacheva, E; Coleman, N; (2004) Paint-assisted microdissection-FISH: Rapid and simple mapping of translocation breakpoints in the embryonal rhabdomyosarcoma cell line RD. Cytometry A , 58 (2) 177 - 184. 10.1002/cyto.a.20025.

Rodriguez-Viciana, P; Sabatier, C; McCormick, F; (2004) Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. MOL CELL BIOL , 24 (11) 4943 - 4954. 10.1128/MCB.24.11.4943-4954.2004.

Rost, S; Fregin, A; Ivaskevicius, V; Conzelmann, E; Hortnagel, K; Pelz, HJ; ... Oldenburg, J; + view all (2004) Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature , 427 (6974) 537 - 541. 10.1038/nature02214.

S

Salomoni, P; Cossarizza, A; (2004) HIV: no PUMA no death? CELL DEATH DIFFER , 11 (7) 691 - 692. 10.1038/sj.cdd.4401446.

Samonakis, DN; Thalheimer, U; Quaglia, A; Mela, M; Triantos, CK; Dhillon, AP; ... Burroughs, AK; + view all (2004) Prospective evaluation of hepatic venous pressure and evolution of recurrent HCV after liver transplantation. HEPATOLOGY , 40 (4) 362A - 362A.

Sartor, O; Reid, RH; Hoskin, PJ; Quick, DP; Ell, PJ; Coleman, RE; ... Quadrament 424Sm10-11 Study Grp,; + view all (2004) Samarium-153-lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer. UROLOGY , 63 (5) 940 - 945. 10.1016/j.urology.2004.01.034.

Saunders, MI; Rojas, AM; (2004) Management of Cancer of the Head and Neck - A Cocktail with Your PORT? New England Journal of Medicine , 350 (19) 1997 - 1999. 10.1056/NEJMe048038.

Self, R; Mackie, I; Jenkins, A; Sanders, J; Williams, A; Machin, S; Mythen, M; (2004) Use of the Thrombelastograph (R) to assess the in vitro effects of DX-88, a novel kallikrein inhibitor, in cardiopulmonary bypass. In: BRITISH JOURNAL OF ANAESTHESIA. (pp. 318P - 318P). OXFORD UNIV PRESS

Shah, FT; Chatterjee, R; Owusu- Asante, M; Porter, JB; (2004) Adults with severe sickle cell anaemia and iron overload have a high incidence of osteopenia and osteoporosis. In: BLOOD. (pp. 468A - 468A). AMER SOC HEMATOLOGY

Shah, FT; Rafique, R; Evan, P; Porter, JB; (2004) Decreased serum pro-hepcidin in thalassaemia intermedia; a mechanism for increased iron absortion mediated though ineffective erthropoiesis and NTBI? In: BLOOD. (pp. 982A - 982A). AMER SOC HEMATOLOGY

Shah, JS; Mehta, A; Hughes, D; Ward, D; Tome, M; Sachdev, B; ... Elliott, PM; + view all (2004) Arrhythmia in Anderson-Fabry disease. In: EUROPEAN HEART JOURNAL. (pp. 539 - 539). W B SAUNDERS CO LTD

Shah, JS; Thaman, R; Hughes, D; Murphy, R; Lee, P; Mehta, A; ... Elliott, PM; + view all (2004) The natural history of left ventricular systolic function in Anderson Fabry's disease (AFD). In: HEART. (pp. A59 - A59). B M J PUBLISHING GROUP

Shaw, BE; Barber, LD; Madrigal, JA; Cleaver, S; Marsh, SGE; (2004) Scoring for HLA matching? A clinical test of HistoCheck. BONE MARROW TRANSPL , 34 (4) 367 - 368. 10.1038/sj.bmt.1704586.

Shaw, BE; Barber, LD; Madrigal, JA; Cleaver, S; Marsh, SGE; Elsner, HA; Blasczyk, R; (2004) Scoring for HLA matching? A clinical test of HistoCheck (multiple letters) [1]. Bone Marrow Transplantation , 34 (4) 367 - 369. 10.1038/sj.bmt.1704586.

Shaw, BE; Maldonado, H; Madrigal, JA; Mayor, NP; Marsh, SGE; Potter, MN; ... Bodmer, JG; + view all (2004) Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation. Tissue Antigens , 63 (5) 401 - 411. 10.1111/j.0001-2815.2004.00218.x.

Shaw, BE; Marsh, SGE; Mayor, NP; Madrigal, JA; (2004) Increased disease relapse in HLA-DPB1 matched recipients of unrelated donor transplants is not confined to pairs matched for the other five HLA loci. In: BLOOD. (pp. 236A - 237A). AMER SOC HEMATOLOGY

Shaw, BE; Marsh, SGE; Mayor, NP; Madrigal, JA; (2004) Matching status at amino acid positions 57 and 65 of the HLA-DPB1 beta chain determines outcome in recipients of unrelated donor haematopoietic stem cell transplants. In: BLOOD. (pp. 236A - 236A). AMER SOC HEMATOLOGY

Shiina, T; Shimizu, S; Hosomichi, K; Kohara, S; Watanabe, S; Hanzawa, K; ... Inoko, H; + view all (2004) Comparative genomic analysis of two avian (quail and chicken) MHC regions. J IMMUNOL , 172 (11) 6751 - 6763.

Short, SC; Suovuori, A; Cook, G; Vivian, G; Harmer, C; (2004) A phase II study using retinoids as redifferentiation agents to increase iodine uptake in metastatic thyroid cancer. Clinical Oncology , 16 (8) 569 - 574.

Sieber, OM; Howarth, KM; Thirlwell, C; Rowan, A; Mandir, N; Goodlad, RA; ... Tomlinson, IPM; + view all (2004) Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (Apc(Min/+)) mice. CANCER RES , 64 (24) 8876 - 8881.

Silverman, GA; Lomas, DA; (2004) Serpin identification, production, and characterization. Methods , 32 (2) 71 - 72.

Steele, AJ; Casanova, AA; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; Jones, DT; Wickremasinghe, RG; (2004) The sesquiterpene lactone parthenolide rapidly and selectively induces apoptosis of B-chronic lymphocytic leukemia cells. In: BLOOD. (pp. 949A - 950A). AMER SOC HEMATOLOGY

Stegert, MR; Tamaskovic, R; Bichsel, SJ; Hergovich, A; Hemmings, BA; (2004) Regulation of NDR2 protein kinase by multi-site phosphorylation and the S100B calcium-binding protein. J BIOL CHEM , 279 (22) 23806 - 23812. 10.1074/jbc.M402472200. Gold open access

Stephens, P; Hunter, C; Bignell, G; Edkins, S; Davies, H; Teague, J; ... Canc Genome Project Collaborat Grp,; + view all (2004) Intragenic ERBB2 kinase mutations in tumours. NATURE , 431 (7008) 525 - 526. 10.1038/431525b.

Stewart, CA; Horton, R; Allcock, RJN; Ashurst, JL; Atrazhev, AM; Coggill, P; ... Beck, S; + view all (2004) Complete MHC haplotype disease gene mapping. GENOME RES , 14 (6) 1176 - 1187. 10.1101/gr.2188104.

Stewart, M; Daniell, K; Madsen, E; Le, M; Handl, H; Brooks, N; ... Lee, M; + view all (2004) Novel class of duocarmycin analogs: Design, synthesis and biological evaluation of achiral analogs of duocarmycin SA. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U29 - U29). AMER CHEMICAL SOC

Strauss, SJ; McTiernan, A; Whelan, JS; (2004) Late relapse of osteosarcoma: Implications for follow-up and screening. Pediatric Blood and Cancer , 43 (6) 692 - 697. 10.1002/pbc.20154.

Strauss, SJ; McTiernan, A; Whelan, JS; (2004) Late relapse of osteosarcoma: Implications for follow-up and screening. PEDIATR BLOOD CANCER , 43 (6) 692 - 697. 10.1002/pbc.20154.

Streck, CJ; Zhang, Y; Miyamoto, R; Zhou, J; Ng, CYC; Nathwani, AC; Davidoff, AM; (2004) Restriction of neuroblastoma angiogenesis and growth by interferon-alpha/beta. In: SURGERY. (pp. 183 - 189). MOSBY, INC

Streck, CJ; Zhang, Y; Miyamoto, R; Zhou, J; Ng, CYC; Nathwani, AC; Davidoff, AM; (2004) Restriction of neuroblastoma angiogenesis and growth by interferon-α/β. Surgery , 136 (2) 183 - 189. 10.1016/j.surg.2004.04.014.

Streck, CJ; Zhou, JF; Ng, CY; Zhang, YB; Nathwani, AC; Davidoff, AM; (2004) Longterm recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in mice with disseminated neuroblastoma. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS , 199 (1) 78 - 86.

Stubbs, M; Khan, K; Watson, SA; Grimes, S; Michaeli, D; Savage, K; ... Caplin, ME; + view all (2004) Specific targeting of CCK-2 receptor on gastric cancer cells with pentagastrin analogues. In: GUT. (pp. A118 - A118). B M J PUBLISHING GROUP

T

Taghian, A; Jagsi, R; Makris, A; Goldberg, S; Ceilley, E; Grignon, L; Powell, S; (2004) Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: Practice is culture driven rather than evidence based. International Journal of Radiation Oncology Biology Physics , 60 (3) 706 - 714.

Taher, A; Aoun, E; Sharara, AI; Mourad, F; Gharzuddine, W; Koussa, S; ... Hoffbrand, AV; + view all (2004) Five-year trial of deferiprone chelation therapy in thalassaemia major patients. ACTA HAEMATOL-BASEL , 112 (4) 179 - 183. 10.1159/000081268.

Tauro, S; Craddock, C; Peggs, K; Begum, G; Chopra, R; Littlewood, T; ... Mackinnon, S; + view all (2004) Outcome of allogeneic stem cell transplantation in adults with high-risk myeloid malignancies using an alemtuzemab based reduced-intensity-conditioning regimen. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 3 - 3). BLACKWELL PUBLISHING LTD

Thomas, R; Godward, S; Makris, A; Bloomfield, D; Moody, AM; Williams, M; (2004) Giving patients a choice improves quality of life: A multi- centre, investigator-blind, randomised, crossover study comparing letrozole with anastrozole. Clinical Oncology , 16 (7) 485 - 491.

Thomson, KJ; Ings, S; Watts, M; Mackinnon, S; Peggs, KS; (2004) CD34(+) cell dose and the occurrence of GVHD in the presence of in vivo T-cell depletion. BLOOD , 103 (2) 743 - 743.

Tikhe, JG; Webber, SE; Hostomsky, Z; Maegley, KA; Ekkers, A; Li, JK; ... Newell, DR; + view all (2004) Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase. J MED CHEM , 47 (22) 5467 - 5481. 10.1021/jm030513r.

Tipping, AJ; Baluch, S; Barnes, DJ; Veach, DR; Clarkson, BM; Bornmann, WG; ... Melo, JV; + view all (2004) Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate. LEUKEMIA , 18 (8) 1352 - 1356. 10.1038/sj.leu.2403416.

Tipping, AJ; Melo, JV; (2004) Comparative gene expression profile of p185(Bcr-Abl) versus p210(Bcr-Abl) expressing cells. LEUKEMIA RES , 28 (3) 219 - 220. 10.1016/j.leukres.2003.07.004.

Tipping, AJ; Vulliamy, TJ; Morgan, NV; Dokal, I; (2004) Molecular diagnosis of Fanconi anemia and dyskeratosis congenita. Methods Mol Med , 91 3 - 17.

Tomita, K; Kibe, T; Kang, HY; Seo, YS; Uritani, M; Ushimaru, T; Ueno, M; (2004) Fission yeast Dna2 is required for generation of the telomeric single-strand overhang. Mol Cell Biol , 24 (21) 9557 - 9567. 10.1128/MCB.24.21.9557-9567.2004.

Tomita, K; Uritani, M; Ushimaru, T; Yoshinaga, K; Ueno, M; (2004) Sequence-specific binding of the Schizosaccharomyces pombe His1 protein to fission yeast telomeric DNA. Chem Biodivers , 1 (9) 1344 - 1353. 10.1002/cbdv.200490097.

Towatari, M; Ciro, M; Ottolenghi, S; Tsuzuki, S; Enver, T; (2004) Involvement of mitogen-activated protein kinase in the cytokineregulated phosphorylation of transcription factor GATA-1. HEMATOL J , 5 (3) 262 - 272.

Tsuzuki, S; Kitajima, K; Nakano, T; Glasow, A; Zelent, A; Enver, T; (2004) Cross talk between retinoic acid signaling and transcription factor GATA-2. MOL CELL BIOL , 24 (15) 6824 - 6836. 10.1128/mcb.24.15.6824-6836.2004.

Tsuzuki, S; Seto, M; Greaves, M; Enver, T; (2004) Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice. P NATL ACAD SCI USA , 101 (22) 8443 - 8448. 10.1073/pnas.0402063101.

Turner, NC; Ledermann, JA; (2004) First -line medical intervention for the treatment of epithelial ovarian cancer. In: Kehoe, S and Gore, M and Miles, A, (eds.) The Effective Management of Ovarian Cancer. (83 - 98). Aesculapius Medical Press: London.

Twelves, C; Gokul, S; Jones, RH; Boddy, A; Macham, M; Fishwick, K; ... Calvert, AH; + view all (2004) Phase I study to evaluate the safety, tolerability and pharmacokinetics of OSI-211 (Liposomal Lurtotecan) in combination with Carboplatin. ANN ONCOL , 15 105 - 105.

U

Ueno, M; Murase, T; Kibe, T; Ohashi, N; Tomita, K; Murakami, Y; ... Harata, M; + view all (2004) Fission yeast Arp6 is required for telomere silencing, but functions independently of Swi6. Nucleic Acids Res , 32 (2) 736 - 741. 10.1093/nar/gkh234. Gold open access

Uramoto, H; Hackzell, A; Wetterskog, D; Ballági, A; Izumi, H; Funa, K; (2004) pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription. J Cell Sci , 117 (Pt 17) 3855 - 3865. 10.1242/jcs.01228.

Uramoto, H; Wetterskog, D; Hackzell, A; Matsumoto, Y; Funa, K; (2004) p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor. J Cell Sci , 117 (Pt 22) 5323 - 5331. 10.1242/jcs.01384.

Urbaniak, MD; Bingham, JP; Hartley, JA; Woolfson, DN; Caddick, S; (2004) Design and synthesis of a nitrogen mustard derivative stabilized by apo-neocarzinostatin. J MED CHEM , 47 (19) 4710 - 4715. 10.1021/jm040790d.

V

van Zuylen, L; Bridgewater, J; Sparreboom, A; Eskens, FALM; de Bruijn, P; Sklenar, I; ... Verweij, J; + view all (2004) Phase I and pharmacokinetic study of the polyamine synthesis inhibitor SAM486A in combination with 5-fluorouracil/leucovorin in metastatic colorectal cancer. CLIN CANCER RES , 10 (6) 1949 - 1955.

Van Zuylen, L; Sparreboom, A; Eskens, FALM; De Bruijn, P; Planting, AST; Verweij, J; ... Mueller, C; + view all (2004) Phase I and Pharmacokinetic Study of the Polyamine Synthesis Inhibitor SAM486A in Combination with 5-Fluorouracil/Leucovorin in Metastatic Colorectal Cancer. Clinical Cancer Research , 10 (6) 1949 - 1955. 10.1158/1078-0432.CCR-02-0995.

Vassileva, V; Millar, A; Briollais, L; Chapman, W; Bapat, B; (2004) Apoptotic and growth regulatory genes as mutational targets in mismatch repair deficient endometrioid adenocarcinomas of young patients. ONCOL REP , 11 (4) 931 - 937.

Venables, K; Miles, EA; Aird, EGA; Hoskin, PJ; (2004) The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial. Radiotherapy and Oncology , 71 (3) 303 - 310.

Venables, K; Miles, EA; Deighton, A; Aird, EGA; Hoskin, PJ; (2004) Irradiation of the heart during tangential breast treatment: a study within the START trial. British Journal of Radiology , 77 (914) 137 - 142.

Vig, S; Chitolie, A; Sleight, S; Bevan, D; Dormandy, J; Thompson, MM; Halliday, A; (2004) Prevalence and risk of thrombophilia defects in vascular patients. EUR J VASC ENDOVASC , 28 (2) 124 - 131. 10.1016/j.ejvs.2004.03.027.

Vig, S; Sleight, S; Chitolie, A; Bevan, DH; Thompson, MM; Dormandy, J; Halliday, A; (2004) Identification of a high-risk subgroup in patients with coronary and peripheral arterial disease. In: BRITISH JOURNAL OF SURGERY. (pp. 143 - 143). JOHN WILEY & SONS LTD

Vig, S; Sleight, S; Chitolie, A; Bevan, DH; Thompson, MM; Dormandy, J; Halliday, A; (2004) Prevalence of thrombophilia in patients with coronary artery and peripheral vascular disease. In: BRITISH JOURNAL OF SURGERY. (pp. 1234 - 1234). JOHN WILEY & SONS LTD

Vineis, P; Alavanja, M; Buffler, P; Fontham, E; Francecshi, S; Gao, YT; ... Doll, R; + view all (2004) Tobacco and cancer: recent epidemiological evidence. Journal of the National Cancer Institute , 96 (2) 99 - 106. 10.1093/jnci/djh014.

Virchis, A; Koh, M; Rankin, P; Mehta, A; Potter, M; Hoffbrand, A; ... H,; + view all (2004) Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes. BRITISH JOURNAL OF HAEMATOLOGY , 124 (1) 26 - 32.

Viviani, B; Bartesaghi, S; Corsini, E; Galli, CL; Marinovich, M; (2004) Cytokines role in neurodegenerative events. TOXICOLOGY LETTERS , 149 (1-3) 85 - 89. 10.1016/j.toxlet.2003.12.022.

W

Waddington, SN; Nivsarkar, M; Mistry, A; Buckley, SMK; Kemball-Cook, G; Mosley, KL; ... Coutelle, C; + view all (2004) Permanent phenotypic correction of Haemophilia B in immunocompetent mice by prenatal gene therapy. In: JOURNAL OF GENE MEDICINE. (pp. S17 - S17). JOHN WILEY & SONS LTD

Waddington, SN; Nivsarkar, MS; Mistry, AR; Buckley, SMK; Kemball-Cook, G; Mosley, KL; ... Coutelle, C; + view all (2004) Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. BLOOD , 104 (9) 2714 - 2721. 10.1182/blood-2004-02-0627.

Wald, NJ; Rodeck, C; Hackshaw, AK; Rudnicka, A; (2004) SURUSS in perspective. BJOG-INT J OBSTET GY , 111 (6) 521 - 531. 10.1111/j.1471-0528.2004.00193.x.

Wald, NJ; Rodeck, CR; Ruldnicka, AR; Hackshaw, AK; (2004) Nuchal translucency and gestational age - Response to Nicolaides. PRENATAL DIAG , 24 (10) 834 - 835. 10.1002/pd.1046.

Walsh, V; Gilkes, AF; Sweeney, M; Austin, SJ; Gale, RE; Mills, KI; (2004) Rapid and quantitative detection of mutations of the FLT3 gene in AML. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 68 - 69). BLACKWELL PUBLISHING LTD

Walton, J; Lawson, K; Manoussaka, MS; Nathwani, A; Emory, V; Lydyard, PM; Porakishvili, N; (2004) Perforin expressing CD4+T cells respond to CMV antigens in CMV seropositive patients with B cell chronic lymphocytic leukaemia (B-CLL). In: BLOOD. (pp. 280B - 280B). AMER SOC HEMATOLOGY

Waterston, A; Thirlwell, C; Newsom-Davis, T; Powles, T; Nelson, M; Gazzard, B; Bower, M; (2004) Does highly active antiretroviral therapy (HAART) affect the incidence or outcome of invasive anal cancer? In: BRITISH JOURNAL OF CANCER. (pp. S13 - S13). NATURE PUBLISHING GROUP

Watts, MJ; Ings, SJ; Balsa, C; Penn, C; Leverett, D; Linch, DC; (2004) Successful customization of peripheral blood stem cell harvest volume and cell concentration during apheresis. In: BLOOD. (pp. 330B - 330B). AMER SOC HEMATOLOGY

Watts, MJ; Ings, SJ; Balsa, C; Penn, C; Linch, DC; (2004) Thermally induced catastrophic cryocyte breaks. In: BONE MARROW TRANSPLANTATION. (pp. S309 - S309). NATURE PUBLISHING GROUP

Westerman, M; Pizzey, A; Hirschman, J; Cerino, M; Eze, A; Ramoton, P; ... Porter, J; + view all (2004) Plasma 'free' HB is related to red cell derived vesicle numbers in sickle cell anemia and thalassemia intermedia: Implications for nitric oxide (NO) scavenging and pulmonary hypertension. In: BLOOD. (pp. 465A - 465A). AMER SOC HEMATOLOGY

Wetterskog, D; Undeland, I; (2004) Loss of redness (a*) as a tool to follow hemoglobin-mediated lipid oxidation in washed cod mince. J Agric Food Chem , 52 (24) 7214 - 7221. 10.1021/jf0307907.

Whelan, J; (2004) Late Effects of Childhood Cancer. Lancet Oncology

Whelan, JS; McTiernan, A; (2004) for the London Bone and Soft Tissue Tumour Service. A prospective study of pre-operative chemotherapy with single agent ifosfamide for malignant fibrous histiocytoma of bone. Sarcoma , 8 77 - 82. Gold open access

Whelan, JS; McTiernan, A; Kakouri, E; Kilby, A; London Bone and Soft Tissue Tumour,; (2004) Carboplatin-based chemotherapy for refractory and recurrent Ewing's tumours. PEDIATR BLOOD CANCER , 43 (3) 237 - 242. 10.1002/pbc.20107.

Whelan, JS; McTiernan, AM; Strauss, SJ; (2004) Single centre experience of a new intensive induction therapy for Ewing’s family of tumours using Holoxan in the VIDE regimen. Final results and conclusions. In: International Society of Paediatric Oncology SIOP XXXV Meeting, Oslo, Norway, September 2004.

Whelan, JS; Morland, B; (2004) Bone Tumours. In: Pinkerton, CR and Plowman, P, (eds.) Paediatric Oncology. Clinical Practice and Controversies. : London.

Whitelegg, A; Barber, LD; (2004) The structural basis of T-cell allorecognition. TISSUE ANTIGENS , 63 (2) 101 - 108.

Williams, KE; Gardiner, C; Mackie, IJ; Machin, SJ; Cohen, H; (2004) Patient self-testing of INR is a safe and acceptable alternative to laboratory-based testing. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 56 - 57). BLACKWELL PUBLISHING LTD

Wilson, C; Nikitenko, LL; Sargent, IL; Rees, MC; (2004) Adrenomedullin: multiple functions in human pregnancy. Angiogenesis , 7 (3) 203 - 212. 10.1007/s10456-004-4183-5.

Y

Yaguchi, H; Ohkura, N; Takahashi, M; Nagamura, Y; Kitabayashi, I; Tsukada, T; (2004) Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway. Mol Cell Biol , 24 (15) 6569 - 6580. 10.1128/MCB.24.15.6569-6580.2004.

Yamano, H; Gannon, J; Mahbubani, H; Hunt, T; (2004) Cell cycle-regulated recognition of the destruction box of cyclin B by the APC/C in Xenopus egg extracts. Mol. Cell , 13 (1) 137 - 147.

Yamano, H; Kominami, K; Harrison, C; Kitamura, K; Katayama, S; Dhut, S; ... Toda, T; + view all (2004) Requirement of the SCFPop1/Pop2 Ubiquitin Ligase for Degradation of the Fission Yeast S Phase Cyclin Cig2. J. Biol. Chem. , 279 (18) 18974 - 18980. Gold open access

Yong, KL; Ahmed, F; Ings, SJ; Pizzey, AR; Blundell, MP; Thrasher, AJ; ... Linch, DC; + view all (2004) Impaired bone marrow homing of cytokine-activated CD34 cells in the NOD/SCID model. Blood , 103 (6) 2079 - 2087. 10.1182/blood-2003-06-1770. Green open access
file

Yung, L; Cunningham, D; Hancock, B; Smith, P; Maclennan, K; Linch, D; McMillan, A; (2004) Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI). Br J Cancer , 91 (4) 695 - 698. 10.1038/sj.bjc.6602031.

Yung, L; Smith, P; Hancock, BW; Hoskin, P; Gilson, D; Vernon, C; Linch, DC; (2004) Long term outcome in adolescents with Hodgkin's lymphoma: Poor results using regimens designed for adults. LEUKEMIA LYMPHOMA , 45 (8) 1579 - 1585. 10.1080/1042819042000209404.

Z

Zelent, A; Greaves, M; Enver, T; (2004) Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia. ONCOGENE , 23 (24) 4275 - 4283. 10.1038/sj.onc.1207672.

Zhou, A; Stein, PE; Huntington, JA; Sivasothy, P; Lomas, DA; Carrell, RW; (2004) How small peptides block and reverse serpin polymerisation. J Mol Biol , 342 (3) 931 - 941. 10.1016/j.jmb.2004.07.078.

This list was generated on Sun May 17 03:42:14 2015 BST.